[1] SPRENGER T, BORSOOK D. Migraine changes the brain: neuroimaging makes its mark[J]. Curr Opin Neurol, 2012, 25(3): 252. doi: 10.1097/WCO.0b013e3283532ca3
[2] SUHR JA, SENG EK. Neuropsychological functioning inmigraine: clinical and research implications[J]. Cephalalgia, 2012, 32(1): 39. doi: 10.1177/0333102411430265
[3] RIST PM, KANG JH, BURING JE, et al. Migraine and cognitive decline among women: prospective cohort study[J]. BMJ, 2012, 345: e5027. doi: 10.1136/bmj.e5027
[4] 李舜伟, 李焰生, 刘若卓, 等. 中国偏头痛诊断治疗指南(2011年版)[J]. 中国疼痛医学杂志, 2011, 17(2): 65. doi: 10.3969/j.issn.1006-9852.2011.02.001
[5] EDWARDS KR, ROSENTHAL BL, FARMER KU, et al. Evaluation of sumatriptan-naproxen in the treatment of acute migraine: a placebo-controlled, double-blind, cross-overstudy assessing cognitive function[J]. Headache, 2013, 53(4): 656. doi: 10.1111/head.12052
[6] LOUTER MA, WARDENAAR KJ, VEEN G, et al. Allodynia is associated with ahigher prevalence of depression inmigraine patients[J]. Cephalalgia, 2014, 34(14): 1187. doi: 10.1177/0333102414532554
[7] RIST PM, SCHURKS M, BURING JE, et al. Migraine, headache, and the risk of depression: prospective cohort study[J]. Cephalalgia, 2013, 33(12): 1017. doi: 10.1177/0333102413483930
[8] KAO CH, WANG SJ, TSAI CF, et al. Psychiatric comorbiditiesin allodynic migraineurs[J]. Cephalalgia, 2014, 34(3): 211. doi: 10.1177/0333102413505238
[9] ASHINA S, SERRANO D, LIPTON RB, et al. Depression andrisk of transformation of episodic to chronic migraine[J]. J Headache Pain, 2012, 13(8): 615. doi: 10.1007/s10194-012-0479-9
[10] YALINAY DIKMEN P, YAVUZ BG, AYDINLAR EI. The relationships between migraine, depression, anxiety, stress, and sleep disturbances[J]. Acta Neurol Belg, 2015, 115(2): 117. doi: 10.1007/s13760-014-0312-0
[11] CHARLES A. The pathophysiology of migraine: implications for clinicalmanagement[J]. Lancet Neurol, 2018, 17(2): 174. doi: 10.1016/S1474-4422(17)30435-0
[12] SENG EK, BUSE DC, KLEPPER JE, et al. Psychological factors associated with chronic migraine and severe migraine-related disability: an observational study in a tertiary headache center[J]. Headache, 2017, 57(4): 593. doi: 10.1111/head.13021
[13] GOMEZ-BELDARRAIN M, ANTON-LADISLAO A, AGUIRRE-LARRACOECHEA U, et al. Low cognitive reserve is associated with chronic migraine with medication overuse and poor quality of life[J]. Cephalalgia, 2015, 35(8): 683. doi: 10.1177/0333102414553822
[14] ZHAO J, LEVY D. Dissociation between CSD-evoked metabolic perturbations and meningeal afferent activation and sensitization: implications for mechanisms of migraine headache onset[J]. J Neurosci, 2018, 38(22): 5053.
[15] KOVACEVIC G, STEVANOVIC D, BOGICEVIC D, et al. A 6-month follow-up of disability, quality of life, and depressive and anxiety symptoms in pediatric migraine with magnesium prophylaxis[J]. Magnes Res, 2017, 30(4): 133. doi: 10.1684/mrh.2018.0431